Dr. Shirin Kalyan is an Assistant Professor in the Division of Endocrinology, Department of Medicine at the University of British Columbia and the Director of Scientific Innovation at Qu Biologics, a clinical-stage Vancouver-based biotech company focused on restoring innate immune function in the context of chronic inflammatory disorders and cancer.
She earned her Ph.D. from the University of British Columbia in Experimental Medicine investigating the pivotal innate immune mediators of inflammation in the context of toxic shock syndrome.
Read Less Read MoreDr. Kalyan was subsequently awarded a 3-year fellowship from the Alexander von Humboldt Foundation to conduct research at the Institute of Immunology in Kiel, Germany. Her research interests include determining how to restore immune function in the context of cancer and chronic inflammatory diseases and understanding how drug therapies commonly used to treat chronic degenerative disorders affect immunity.
To mark International Women's Day, this edition summarizes a selection of women's health research from CHÉOS Scientists: cancer screening; anal sphincter injury; and contraception
Read More
Read about the Scientists and research that appeared in the media this summer.
Read More
The twenty-fourth instalment of "The Evidence Speaks" Series includes some of the latest research from CHÉOS Scientists, featuring Drs. Lynd, Lauck, and Kalyan.
Read More
